International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis — ALTO  

Allergic Rhinitis Due to Grass Pollens Clinical Trial

Official title: An International Non-Interventional Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis Treated With Oralair®.

Status Terminated

Clinical Trial Summary

The purpose of the present study is to describe patient's perception of quality of life and effectiveness of ORALAIR® over a follow-up period up to 5 years, in real-life settings.

Clinical Trial Description

Primary objective:

To describe the patient's perception of the impact of ORALAIR® on his/her health related generic and disease specific quality of life during the grass pollen season in real-life settings.

Secondary objectives:

• To describe the patient's perceived effectiveness of ORALAIR® in allergic rhinoconjunctivitis management in terms of disease intensity, satisfaction and rescue medication ;

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Allergic Rhinitis Due to Grass Pollens
• Rhinitis

• NCT number: NCT02041624
• Study type: Observational [Patient Registry]
• Source: Stallergenes
• Status: Terminated
• Phase: N/A
• Start date: May 2014
• Completion date: December 2015